Home › Astrocytoma › District of Columbia
Astrocytoma clinical trials in District of Columbia
4 studies for Astrocytoma are looking for participants at sites in District of Columbia.
Cities in District of Columbia
Targeted Pediatric High-Grade Glioma Therapy
- Children's National Medical Center, Washington D.C.
RecruitingObservational study
12 Months – 39 Years · All sexes · Updated Sep 8, 2026 · NCT05839379Study of Olutasidenib and Temozolomide in HGG
- Children's National Medical Center, Washington D.C.
RecruitingPhase 2
Ages 12 to 39 · All sexes · Updated Sep 1, 2026 · NCT06161974Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Children's National Medical Center, Washington D.C.
RecruitingEarly phase 1Healthy volunteers welcome
Ages 1 to 21 · All sexes · Updated Jun 29, 2026 · NCT06333899Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Children's National Medical Center, Washington D.C.
RecruitingPhase 2
12 Months – 39 Years · All sexes · Updated May 29, 2026 · NCT05843253From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.